Disseminated bcg disease associated with immunotherapy by scarification in acute leukemia
β Scribed by Paul S. Ritch; Kenneth B. McCredie; Jordan U. Gutterman; Evan M. Hersh
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- English
- Weight
- 407 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Twelve children with acute lymphocytic leukemia who had been in complete remission on continuous chemotherapy for at least 12 months, were treated with intermittent courses of chemotherapy alternating with BCGBCG: CalmetteβGuΓ©rin strain of Mycobacterium bovis. inoculation during the dr
## Abstract Specific immunotherapies for patients with acute myeloid leukemia (AML) using leukemiaβassociated antigens (LAA) as target structures might be a therapeutic option to enhance the graftβ__vs__.βleukemia effect observed after allogeneic stem cell transplantation or to prolong a complete r
To the Editor: Immunomodulatory therapies such as 6-mercaptopurine (6-MP) and azathioprine provide high remission rates and success in avoiding steroid dependence in patients with inflammatory bowel disease (IBD). However, these treatments are not without adverse effects including leukopenia, liver